Annual Shareholders Equity
$49.91 M
+$3.67 M+7.93%
December 1, 2023
Summary
- As of February 8, 2025, IRD annual stockholders equity is $49.91 million, with the most recent change of +$3.67 million (+7.93%) on December 1, 2023.
- During the last 3 years, IRD annual shareholders equity has risen by +$63.37 million (+470.58%).
- IRD annual shareholders equity is now at all-time high.
Performance
IRD Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$34.30 M
-$6.34 M-15.59%
September 1, 2024
Summary
- As of February 8, 2025, IRD quarterly stockholders equity is $34.30 million, with the most recent change of -$6.34 million (-15.59%) on September 1, 2024.
- Over the past year, IRD quarterly shareholders equity has dropped by -$11.76 million (-25.53%).
- IRD quarterly shareholders equity is now -31.78% below its all-time high of $50.28 million, reached on September 1, 2023.
Performance
IRD Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
IRD Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.9% | -25.5% |
| 3 y3 years | +470.6% | +54.4% |
| 5 y5 years | +760.1% | +54.4% |
IRD Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +124.6% | -31.8% | +188.8% |
| 5 y | 5-year | at high | +470.6% | -31.8% | +354.7% |
| alltime | all time | at high | +470.6% | -31.8% | +354.7% |
Opus Genetics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $34.30 M(-15.6%) |
| Jun 2024 | - | $40.64 M(-11.8%) |
| Mar 2024 | - | $46.06 M(-7.7%) |
| Dec 2023 | $49.91 M(+7.9%) | $49.91 M(-0.7%) |
| Sep 2023 | - | $50.28 M(+33.4%) |
| Jun 2023 | - | $37.70 M(-8.6%) |
| Mar 2023 | - | $41.25 M(-10.8%) |
| Dec 2022 | $46.24 M | $46.24 M(+289.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $11.88 M(-18.6%) |
| Jun 2022 | - | $14.60 M(-15.5%) |
| Mar 2022 | - | $17.27 M(-22.3%) |
| Dec 2021 | $22.22 M(-265.0%) | $22.22 M(+8.1%) |
| Sep 2021 | - | $20.57 M(-8.8%) |
| Jun 2021 | - | $22.55 M(+129.8%) |
| Mar 2021 | - | $9.82 M(-172.9%) |
| Dec 2020 | -$13.47 M(+78.1%) | -$13.47 M |
| Dec 2019 | -$7.56 M | - |
FAQ
- What is Opus Genetics annual stockholders equity?
- What is the all time high annual shareholders equity for Opus Genetics?
- What is Opus Genetics annual shareholders equity year-on-year change?
- What is Opus Genetics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Opus Genetics?
- What is Opus Genetics quarterly shareholders equity year-on-year change?
What is Opus Genetics annual stockholders equity?
The current annual shareholders equity of IRD is $49.91 M
What is the all time high annual shareholders equity for Opus Genetics?
Opus Genetics all-time high annual stockholders equity is $49.91 M
What is Opus Genetics annual shareholders equity year-on-year change?
Over the past year, IRD annual stockholders equity has changed by +$3.67 M (+7.93%)
What is Opus Genetics quarterly stockholders equity?
The current quarterly shareholders equity of IRD is $34.30 M
What is the all time high quarterly shareholders equity for Opus Genetics?
Opus Genetics all-time high quarterly stockholders equity is $50.28 M
What is Opus Genetics quarterly shareholders equity year-on-year change?
Over the past year, IRD quarterly stockholders equity has changed by -$11.76 M (-25.53%)